Posted On: 12/05/2012 8:15:02 AM
Post# of 28539

Agreement Reached With FDA on Pivotal Trial Design for Its Novel Targeted Therapy Cotara for the Treatment of Recurrent Brain Cancer; Agreement Allows for Phase III Trial Planning While Advancing Partnering Discussions
View More
View More

